Children's Oncology Group's 2023 blueprint for research: Rare tumors

Kris Ann P. Schultz,Murali Chintagumpala,Jin S. Piao,Kenneth S. Chen,Robyn Gartrell,Emily L. Christison-Lagay,Jesse L. Berry,Rachana W. Shah,Theodore W. Laetsch, Childrens Oncol Grp Rare Tumor Comm

Pediatric blood & cancer（2023）

引用 0|浏览1

暂无评分

摘要

The Children's Oncology Group (COG) Rare Tumor Committee includes the Infrequent Tumor and Retinoblastoma subcommittees, encompassing a wide range of extracranial solid tumors that do not fall within another COG disease committee. Current therapeutic trial development focuses on nasopharyngeal carcinoma, adrenocortical carcinoma, pleuropulmonary blastoma, colorectal carcinoma, melanoma, and thyroid carcinoma. Given the rarity of these tumors, novel strategies and international collaborative efforts are necessary to advance research and improve outcomes.

查看译文

关键词

Adrenocortical carcinoma,Children's Oncology Group,colorectal carcinoma,nasopharyngeal carcinoma,pleuropulmonary blastoma,rare cancer,rare tumor,retinoblastoma,thyroid cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要